ArticleCancers2021

Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer.

Anello Marcello Poma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.